300896:SZSEIMEIK Technology Development Co., Ltd. Class A Analysis
Data as of 2026-09-03 - not real-time
CN¥91.25
Latest Price
6/10Risk
Risk Level: Medium
Executive Summary
Imeik Technology Development Co.,Ltd. is priced at ¥91.25, and its moving averages give no clean directional read — the structure is neutral. The last 30 days have lost 13.1%. RSI sits at 38.1, which reads as approaching oversold, and MACD momentum is bearish. Recent trading has carved out support near ¥91.00 and resistance around ¥108.23.
Valuation screens as undervalued: a P/E of 25.6 sits below the sector average of 30.9. Sell-side targets cluster 46.2% above the current quote. Revenue is contracting at 8.5% on a 46.2% profit margin. The 1.94% dividend yield looks covered by current payout levels.
Risk comes out at 6 of a possible 10, a elevated reading. With 30-day volatility of 39.2%, a beta of 0.29 and a maximum drawdown of 57.5%, position sizing matters here. The wider market backdrop reads extreme greed at 96 on the fear-greed composite.
Short, medium and long-term reads agree on hold, with conviction of 3/10.
Valuation screens as undervalued: a P/E of 25.6 sits below the sector average of 30.9. Sell-side targets cluster 46.2% above the current quote. Revenue is contracting at 8.5% on a 46.2% profit margin. The 1.94% dividend yield looks covered by current payout levels.
Risk comes out at 6 of a possible 10, a elevated reading. With 30-day volatility of 39.2%, a beta of 0.29 and a maximum drawdown of 57.5%, position sizing matters here. The wider market backdrop reads extreme greed at 96 on the fear-greed composite.
Short, medium and long-term reads agree on hold, with conviction of 3/10.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 1/10
Key Factors
- Trading below the 200-day average of 121.27
- MACD momentum is negative
- 30-day price change of -13.1%
Medium Term
1–3 yearsNeutral
Model confidence: 2/10
Key Factors
- P/E of 25.6 versus sector average of 30.9
- Trading below the 200-day average of 121.27
- Analyst targets imply +46.2% versus the current price
Long Term
> 3 yearsNeutral
Model confidence: 3/10
Key Factors
- P/E of 25.6 versus sector average of 30.9
- Analyst targets imply +46.2% versus the current price
- Profit margin of 46.2% is healthy
Key Metrics & Analysis
Financial Health
Revenue Growth-8.50%
Profit Margin46.22%
P/E Ratio25.6
ROE13.44%
ROA7.74%
Debt/Equity0.35
P/B Ratio3.5
Op. Cash FlowCN¥1.2B
Free Cash FlowCN¥832.0M
Industry P/E30.9
Technical Analysis
TrendNeutral
RSI38.1
SupportCN¥91.00
ResistanceCN¥108.23
MA 20CN¥97.03
MA 50CN¥96.89
MA 200CN¥121.27
MACDBearish
VolumeDecreasing
Fear & Greed Index95.86
Valuation
Fair ValueCN¥48.41
Target PriceCN¥133.40
Upside/Downside46.19%
GradeUndervalued
TypeBlend
Dividend Yield1.94%
Risk Assessment
Beta0.29
Volatility39.24%
Sector RiskMedium
Reg. RiskHigh
Geo RiskHigh
Currency RiskHigh
Liquidity RiskLow
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.